Source link : https://www.newshealth.biz/health-news/anti-tnf-therapy-lowers-gestational-diabetes-risk-in-ibd/

TOPLINE: Exposure to antitumor necrosis factor (anti-TNF) therapy during the first 140 days of pregnancy is associated with a significant decrease in the risk of developing gestational diabetes (GD) among women with inflammatory bowel disease (IBD). METHODOLOGY: Elevated levels of TNF have been observed in women with GD, suggesting a potential protective effect of anti-TNF […]

Author : News Health

Publish date : 2024-11-22 09:49:24

Copyright for syndicated content belongs to the linked Source.